Once COVID-19 hit, the demand for mental health services skyrocketed, and with in-person care suspended, many turned to digital services — which led to a disturbing breach of data privacy.
The Duke Sanford School of Public Policy conducted a data brokerage study that found sensitive mental and physical health information was being collected, aggregated, bought, and sold by digital mental health service apps. And those services, in many cases, were not bound by HIPAA regulations.
The list of buyers of the personal health information is vast that includes banks and other financial institutions, US law enforcement agencies, advertising firms, insurance providers — and scammers.
Some digital health service platforms priced the health data of its customers between $200 and $5,000, while others offered subscriptions that doled out information monthly for $75,000 to $100,000.
So what's up for sale? The study found that some services were selling data on anonymous customers, others sold information that included a person's age, sex, race, postal code, and mental health status.
Earlier this month, the Federal Trade Commission filed an order with the Justice Department against GoodRx, a leader in American healthcare and operator of a telemedicine platform, for illegally sharing user information with advertising behemoths like Facebook and Google. The company has since agreed to pay a $1.5 million fine. If the suit is honored in court, it would ban GoodRx from sharing sensitive personal data with third parties.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
A Minnesota utility began shutting down a nuclear power plant near Minneapolis on Friday after discovering water containing a low level of radioactive material was leaking from a pipe for the second time. While the utility and health officials say it is not dangerous, the issue has prompted concerns among nearby residents and raised questions about aging pipelines.
